Australian doctors and mental health professionals have positive views about using psychedelics like psilocybin and MDMA to treat depression and trauma, which were recently approved by regulators. However, many still have safety concerns and gaps in their knowledge, particularly psychiatrists. Most doctors learn about psychedelics from podcasts and websites rather than formal training. The study recommends that professional organizations provide better education to prepare healthcare workers for this new treatment approach.